Insmed Incorporated (INSM)
NASDAQ: INSM · Real-Time Price · USD
96.88
-1.10 (-1.12%)
At close: Jun 12, 2025, 4:00 PM
95.50
-1.38 (-1.42%)
Pre-market: Jun 13, 2025, 7:08 AM EDT
Insmed Employees
Insmed had 1,271 employees as of December 31, 2024. The number of employees increased by 359 or 39.36% compared to the previous year.
Employees
1,271
Change (1Y)
359
Growth (1Y)
39.36%
Revenue / Employee
$299,788
Profits / Employee
-$797,218
Market Cap
17.65B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
INSM News
- 1 day ago - Insmed Announces Pricing of $750 Million Public Offering of Common Stock - PRNewsWire
- 1 day ago - Insmed Announces Proposed $650 Million Public Offering of Common Stock - PRNewsWire
- 1 day ago - Insmed's Pulmonary Hypertension Drug Data Exceeded Even Bullish Outlook, Analysts Boost Price Forecast - Benzinga
- 2 days ago - Insmed: Company Presses On With Further POC PAH Treatment Data - Seeking Alpha
- 2 days ago - Insmed's blood pressure drug meets main goal in mid-stage trial - Reuters
- 3 days ago - Insmed Announces Positive Topline Results from Phase 2b Study of Treprostinil Palmitil Inhalation Powder (TPIP) as Once-Daily Therapy in Patients with Pulmonary Arterial Hypertension - PRNewsWire
- 8 days ago - Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - PRNewsWire
- 16 days ago - Insmed To Present at the 2025 Goldman Sachs Annual Global Healthcare Conference - PRNewsWire